Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.81 - $2.53 $580 - $1,814
-717 Reduced 18.58%
3,141 $2,000
Q1 2022

May 16, 2022

SELL
$2.53 - $3.9 $20,343 - $31,359
-8,041 Reduced 67.58%
3,858 $10,000
Q4 2021

Feb 08, 2022

BUY
$3.27 - $6.38 $15,519 - $30,279
4,746 Added 66.35%
11,899 $47,000
Q3 2021

Nov 15, 2021

BUY
$5.11 - $10.81 $35,826 - $75,788
7,011 Added 4937.32%
7,153 $39,000
Q2 2021

Sep 13, 2021

BUY
$6.7 - $11.98 $951 - $1,701
142 New
142 $1,000

About 180 Life Sciences Corp.


  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $141M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.